相关实验视频
Updated: Jan 8, 2026

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
12.9K
抗凝血和静血在体外膜氧化患者中的抗凝血和静血
Ouriel Saura1,2, David Levy1,2, Matthieu Schmidt1,2
1Institute of Cardiometabolism and Nutrition, Sorbonne Université, INSERM, UMRS_1166-ICAN.
Current opinion in anaesthesiology
|December 12, 2025
概括
在体外膜氧化 (ECMO) 期间管理出血和血栓形成需要了解复杂的静血性障碍. 目前的策略包括先进的监测和替代抗凝剂,以改善患者的治疗结果.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 进行心血管外科手术.
背景情况:
- 身体外膜氧化 (ECMO) 是一种与严重出血和血栓性并发症相关的生命支持技术.
- 了解ECMO期间复杂的静血机制对于患者管理至关重要.
研究的目的:
- 在ECMO中提供血液静止障碍和抗凝固管理的最新审查.
- 强调出血和血栓形成的双重风险背后的机制.
- 讨论当前的治疗策略和未来的方向.
主要方法:
- 关于ECMO相关的血液静止和抗凝固的当前文献的综述.
- 对出血和血栓形成的机理性见解的分析.
- 对治疗策略和监测技术的评估.
主要成果:
- 出血和血栓事件影响高达50%的ECMO患者.
- 关键因素包括血小板功能障碍,获得的·维勒布兰德综合征,纤维溶解失衡和血液溶解.
- 标准是未分离的肝素,替代品是比瓦利鲁丁;先进的监测辅助抗凝血定位.
结论:
- 在ECMO中,静血问题源于患者因素,电路应力和抗凝.
- 预防出血和血栓形成需要了解这些复杂的相互作用.
- 个性化抗凝协议和改进的电路是未来的目标.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
175
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
175
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
354
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
354

